Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolutionary history of human colitis-associated colorectal cancer
Ann‐Marie Baker, William Cross, Kit Curtius, et al.
Gut (2018) Vol. 68, Iss. 6, pp. 985-995
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Resolving genetic heterogeneity in cancer
Samra Turajlic, Andrea Sottoriva, Trevor A. Graham, et al.
Nature Reviews Genetics (2019) Vol. 20, Iss. 7, pp. 404-416
Open Access | Times Cited: 559
Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management
Shailja C. Shah, Steven H. Itzkowitz
Gastroenterology (2021) Vol. 162, Iss. 3, pp. 715-730.e3
Open Access | Times Cited: 470
Genetic and biological hallmarks of colorectal cancer
Jiexi Li, Xingdi Ma, Deepavali Chakravarti, et al.
Genes & Development (2021) Vol. 35, Iss. 11-12, pp. 787-820
Open Access | Times Cited: 373
Somatic inflammatory gene mutations in human ulcerative colitis epithelium
Kosaku Nanki, Masayuki Fujii, Mariko Shimokawa, et al.
Nature (2019) Vol. 577, Iss. 7789, pp. 254-259
Closed Access | Times Cited: 267
Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis
Nobuyuki Kakiuchi, Kenichi Yoshida, Motoi Uchino, et al.
Nature (2019) Vol. 577, Iss. 7789, pp. 260-265
Open Access | Times Cited: 211
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Chao Liu, Ruiqi Liu, Bojun Wang, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001895-e001895
Open Access | Times Cited: 167
Somatic Evolution in Non-neoplastic IBD-Affected Colon
Sigurgeir Ólafsson, Rebecca E. McIntyre, Tim H. H. Coorens, et al.
Cell (2020) Vol. 182, Iss. 3, pp. 672-684.e11
Open Access | Times Cited: 165
Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease–Associated Colorectal Cancer
Kristiina Rajamäki, Aurora Taira, Riku Katainen, et al.
Gastroenterology (2021) Vol. 161, Iss. 2, pp. 592-607
Open Access | Times Cited: 160
Oral Metal‐Free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD)
Qiong Huang, Yuqi Yang, Yan Zhu, et al.
Small (2023) Vol. 19, Iss. 19
Closed Access | Times Cited: 80
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 59
Mitochondrial function and gastrointestinal diseases
Parsa Haque, Neeraj Kapur, Terrence A. Barrett, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 8, pp. 537-555
Closed Access | Times Cited: 22
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies
Massimo Claudio Fantini, I. Guadagni
Digestive and Liver Disease (2021) Vol. 53, Iss. 5, pp. 558-565
Closed Access | Times Cited: 91
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
Marianna Lucafò, Debora Curci, Martina Franzin, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 88
Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines
Ross J Porter, Mark J. Arends, A. M. D. Churchhouse, et al.
Journal of Crohn s and Colitis (2021) Vol. 15, Iss. 12, pp. 2131-2141
Open Access | Times Cited: 86
The “unnatural” history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance
Aysel Ahadova, Toni T. Seppälä, Christoph Engel, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 4, pp. 800-811
Open Access | Times Cited: 84
Chitosan-Based Nanocomposite Polymeric Membranes for Water Purification—A Review
Angela Spoială, Cornelia-Ioana Ilie, Denisa Ficai, et al.
Materials (2021) Vol. 14, Iss. 9, pp. 2091-2091
Open Access | Times Cited: 82
Translating insights into tumor evolution to clinical practice: promises and challenges
Matthew W. Fittall, Peter Van Loo
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 77
Normal tissue architecture determines the evolutionary course of cancer
Jeffrey West, Ryan O. Schenck, Chandler Gatenbee, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 72
Molecular Network of Colorectal Cancer and Current Therapeutic Options
Zhe Huang, Mingli Yang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 58
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
Wantao Wu, Yihan Liu, Shan Zeng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 57
Molecular mechanisms in colitis-associated colorectal cancer
Royce Zhou, Noam Harpaz, Steven H. Itzkowitz, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
Walid K. Chatila, Henry Walch, Jaclyn F. Hechtman, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Pharmacodynamic components and mechanisms of ginger (Zingiber officinale) in the prevention and treatment of colorectal cancer
Si-Rui Xiang, Jian Qin, Chen Wu, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117733-117733
Closed Access | Times Cited: 10
Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer
Natalia Sampaio Moura, Alyssa Schledwitz, Madeline Alizadeh, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 10
Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis
Ibrahim Al Bakir, Kit Curtius, George D. Cresswell, et al.
Gut (2025), pp. gutjnl-333353
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top